Johanna Mercier is the Chief Commercial Officer at Gilead Sciences Inc., a biopharmaceutical company focused on developing innovative therapies for life-threatening diseases. With an extensive background in the pharmaceutical industry, Mercier has played a pivotal role in shaping Gilead's commercial strategy and driving the company's growth. Prior to joining Gilead, she held various leadership positions at major pharmaceutical companies, where she gained valuable experience in sales, marketing, and business development. As Chief Commercial Officer, Mercier is responsible for overseeing Gilead's global commercial operations, including sales, marketing, and market access. Her strategic vision and leadership have been instrumental in the successful launch and commercialization of several of Gilead's groundbreaking therapies, such as those for HIV, hepatitis C, and oncology. Mercier's ability to navigate complex market dynamics and build strong relationships with healthcare providers and stakeholders has contributed to Gilead's position as a leader in the biopharmaceutical industry. Throughout her career, Mercier has been recognized for her achievements in driving commercial success and fostering a culture of innovation. Her dedication to improving patient outcomes and her commitment to Gilead's mission have made her an invaluable asset to the company. As Chief Commercial Officer, Mercier continues to lead Gilead's efforts to expand access to life-saving therapies and bring hope to patients worldwide.